Coronary Arteriosclerosis Global Clinical Trials Review, H2, 2017

2017-07-19
Price :
Published : Jul-2017
No. of Pages : 67
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials 19
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 26
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Coronary Arteriosclerosis Therapeutics Clinical Trials 31
Prominent Drugs 33
Clinical Trial Profile Snapshots 34
Appendix 65
Abbreviations 65
Definitions 65
Research Methodology 66
Secondary Research 66
About GlobalData 67
Contact Us 67
Source 67

List of Tables
Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Region, 2017* 6
Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Coronary Arteriosclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
Coronary Arteriosclerosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
Coronary Arteriosclerosis Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Coronary Arteriosclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
Coronary Arteriosclerosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 14
Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 16
Coronary Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Coronary Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 20
Coronary Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
Coronary Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 22
Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Phase, 2017* 23
Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 24
Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 25
Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26
Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27
Coronary Arteriosclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 28
Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 30
Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 32
Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 33

List of Figures
Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Coronary Arteriosclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
Coronary Arteriosclerosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Coronary Arteriosclerosis Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Coronary Arteriosclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 13
Coronary Arteriosclerosis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 14
Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 15
Coronary Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Coronary Arteriosclerosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Coronary Arteriosclerosis to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 19
Coronary Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21
Coronary Arteriosclerosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 22
Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Phase (%), 2017* 23
Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 24
Coronary Arteriosclerosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 25
Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26
Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27
Coronary Arteriosclerosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 28
Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 31
Coronary Arteriosclerosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 33
GlobalData Methodology 66
Filed in: Pharmaceutical
Publisher : GlobalData